TY - JOUR AU - Mantovani, A. AU - Bonecchi, R. AU - Locati, M. PY - 2006 DA - 2006// TI - Tuning inflammation and immunity by chemokine sequestration: decoys and more JO - Nat Rev Immunol VL - 6 UR - https://doi.org/10.1038/nri1964 DO - 10.1038/nri1964 ID - Mantovani2006 ER - TY - JOUR AU - Balkwill, F. PY - 2004 DA - 2004// TI - Cancer and the chemokine network JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1388 DO - 10.1038/nrc1388 ID - Balkwill2004 ER - TY - JOUR AU - Keeley, E. C. AU - Mehrad, B. AU - Strieter, R. M. PY - 2008 DA - 2008// TI - Chemokines as mediators of neovascularization JO - Arterioscler Thromb Vasc Biol VL - 28 UR - https://doi.org/10.1161/ATVBAHA.108.162925 DO - 10.1161/ATVBAHA.108.162925 ID - Keeley2008 ER - TY - JOUR AU - Ben-Baruch, A. PY - 2008 DA - 2008// TI - Organ selectivity in metastasis: regulation by chemokines and their receptors JO - Clin Exp Metastasis VL - 25 UR - https://doi.org/10.1007/s10585-007-9097-3 DO - 10.1007/s10585-007-9097-3 ID - Ben-Baruch2008 ER - TY - JOUR AU - Garin, A. AU - Proudfoot, A. E. I. PY - 2011 DA - 2011// TI - Chemokines as targets for therapy JO - Exp Cell Res VL - 317 UR - https://doi.org/10.1016/j.yexcr.2010.12.021 DO - 10.1016/j.yexcr.2010.12.021 ID - Garin2011 ER - TY - JOUR AU - Mishra, P. AU - Banerjee, D. AU - Ben-Baruch, A. PY - 2010 DA - 2010// TI - Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy JO - J Leukoc Biol VL - 89 UR - https://doi.org/10.1189/jlb.0310182 DO - 10.1189/jlb.0310182 ID - Mishra2010 ER - TY - JOUR AU - Muller, A. AU - Homey, B. AU - Soto, H. AU - Ge, N. AU - Catron, D. AU - Buchanan, M. E. PY - 2001 DA - 2001// TI - Involvement of chemokine receptors in breast cancer metastasis JO - Nature VL - 410 UR - https://doi.org/10.1038/35065016 DO - 10.1038/35065016 ID - Muller2001 ER - TY - JOUR AU - Ding, Y. AU - Shimada, Y. AU - Maeda, M. AU - Kawabe, A. AU - Kaganoi, J. AU - Komoto, I. PY - 2003 DA - 2003// TI - Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma JO - Clin Cancer Res VL - 9 ID - Ding2003 ER - TY - JOUR AU - Takeuchi, H. AU - Fujimoto, A. AU - Tanaka, M. AU - Yamano, T. AU - Hsueh, E. AU - Hoon, D. S. PY - 2004 DA - 2004// TI - CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0195 DO - 10.1158/1078-0432.CCR-03-0195 ID - Takeuchi2004 ER - TY - JOUR AU - Cabioglu, N. AU - Yazici, M. S. AU - Arun, B. AU - Broglio, K. R. AU - Hortobagyi, G. N. AU - Price, J. E. PY - 2005 DA - 2005// TI - CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0014 DO - 10.1158/1078-0432.CCR-05-0014 ID - Cabioglu2005 ER - TY - JOUR AU - Sancho, M. AU - Vieira, J. M. AU - Casalou, C. AU - Mesquita, M. AU - Pereira, T. AU - Cavaco, B. M. PY - 2006 DA - 2006// TI - Expression and function of the chemokine receptor CCR7 in thyroid carcinomas JO - J Endocrinol VL - 191 UR - https://doi.org/10.1677/joe.1.06688 DO - 10.1677/joe.1.06688 ID - Sancho2006 ER - TY - JOUR AU - Sun, R. H. AU - Wang, G. B. AU - Li, J. AU - Cui, J. PY - 2009 DA - 2009// TI - [Role of CCL21/CCR7 in invasion of colorectal carcinoma cell line SW480] JO - Ai Zheng VL - 28 ID - Sun2009 ER - TY - JOUR AU - Liu, Y. AU - Ji, R. AU - Li, J. AU - Gu, Q. AU - Zhao, X. AU - Sun, T. PY - 2010 DA - 2010// TI - Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis JO - J Exp Clin Cancer Res VL - 29 UR - https://doi.org/10.1186/1756-9966-29-16 DO - 10.1186/1756-9966-29-16 ID - Liu2010 ER - TY - JOUR AU - Wang, J. AU - Seethala, R. R. AU - Zhang, Q. AU - Gooding, W. AU - Waes, C. AU - Hasegawa, H. PY - 2008 DA - 2008// TI - Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn059 DO - 10.1093/jnci/djn059 ID - Wang2008 ER - TY - JOUR AU - Andre, F. AU - Cabioglu, N. AU - Assi, H. AU - Sabourin, J. C. AU - Delaloge, S. AU - Sahin, A. PY - 2006 DA - 2006// TI - Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdl053 DO - 10.1093/annonc/mdl053 ID - Andre2006 ER - TY - STD TI - Zhao B, Cui K, Wang C-L, Wang A-L, Zhang B, Zhou W-Y, et al. The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. Journal of Hepato-Biliary-Pancreatic Sciences 2011;18:821–8. ID - ref16 ER - TY - JOUR AU - Guo, J. AU - Lou, W. AU - Ji, Y. AU - Zhang, S. PY - 2013 DA - 2013// TI - Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma JO - Oncol Lett VL - 5 ID - Guo2013 ER - TY - JOUR AU - Shields, J. D. AU - Emmett, M. S. AU - Dunn, D. B. AU - Joory, K. D. AU - Sage, L. M. AU - Rigby, H. PY - 2007 DA - 2007// TI - Chemokine-mediated migration of melanoma cells towards lymphatics–a mechanism contributing to metastasis JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210114 DO - 10.1038/sj.onc.1210114 ID - Shields2007 ER - TY - JOUR AU - Shields, J. D. AU - Fleury, M. E. AU - Yong, C. AU - Tomei, A. A. AU - Randolph, G. J. AU - Swartz, M. A. PY - 2007 DA - 2007// TI - Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling JO - Cancer Cell VL - 11 UR - https://doi.org/10.1016/j.ccr.2007.04.020 DO - 10.1016/j.ccr.2007.04.020 ID - Shields2007 ER - TY - JOUR AU - Pan, M. R. AU - Hou, M. F. AU - Chang, H. C. AU - Hung, W. C. PY - 2008 DA - 2008// TI - Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M710038200 DO - 10.1074/jbc.M710038200 ID - Pan2008 ER - TY - JOUR AU - Issa, A. AU - Le, T. X. AU - Shoushtari, A. N. AU - Shields, J. D. AU - Swartz, M. A. PY - 2009 DA - 2009// TI - Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-1875 DO - 10.1158/0008-5472.CAN-08-1875 ID - Issa2009 ER - TY - JOUR AU - Shields, J. D. AU - Kourtis, I. C. AU - Tomei, A. A. AU - Roberts, J. M. AU - Swartz, M. A. PY - 2010 DA - 2010// TI - Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21 JO - Science VL - 328 UR - https://doi.org/10.1126/science.1185837 DO - 10.1126/science.1185837 ID - Shields2010 ER - TY - JOUR AU - Yu, M. AU - Tang, Z. AU - Alousi, S. AU - Berk, R. S. AU - Miller, F. AU - Kosir, M. A. PY - 2007 DA - 2007// TI - Expression patterns of lymphangiogenic and angiogenic factors in a model of breast ductal carcinoma in situ JO - Am J Surg VL - 194 UR - https://doi.org/10.1016/j.amjsurg.2007.08.007 DO - 10.1016/j.amjsurg.2007.08.007 ID - Yu2007 ER - TY - JOUR AU - Skobe, M. AU - Hawighorst, T. AU - Jackson, D. G. AU - Prevo, R. AU - Janes, L. AU - Velasco, P. PY - 2001 DA - 2001// TI - Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis JO - Nat Med VL - 7 UR - https://doi.org/10.1038/84643 DO - 10.1038/84643 ID - Skobe2001 ER - TY - JOUR AU - Mandriota, S. J. AU - Jussila, L. AU - Jeltsch, M. AU - Compagni, A. AU - Baetens, D. AU - Prevo, R. PY - 2001 DA - 2001// TI - Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis JO - EMBO J VL - 20 UR - https://doi.org/10.1093/emboj/20.4.672 DO - 10.1093/emboj/20.4.672 ID - Mandriota2001 ER - TY - JOUR AU - He, Y. AU - Rajantie, I. AU - Pajusola, K. AU - Jeltsch, M. AU - Holopainen, T. AU - Yla-Herttuala, S. PY - 2005 DA - 2005// TI - Vascular endothelial cell growth factor receptor 3–mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-4576 DO - 10.1158/0008-5472.CAN-04-4576 ID - He2005 ER - TY - JOUR AU - Timoshenko, A. V. AU - Rastogi, S. AU - Lala, P. K. PY - 2007 DA - 2007// TI - Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells JO - Br J Cancer VL - 97 UR - https://doi.org/10.1038/sj.bjc.6603993 DO - 10.1038/sj.bjc.6603993 ID - Timoshenko2007 ER - TY - JOUR AU - Majumder, M. AU - Tutunea-Fatan, E. AU - Xin, X. AU - Rodriguez-Torres, M. AU - Torres-Garcia, J. AU - Wiebe, R. PY - 2012 DA - 2012// TI - Co-expression of alpha9beta1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0035094 DO - 10.1371/journal.pone.0035094 ID - Majumder2012 ER - TY - JOUR AU - Rozic, J. G. AU - Chakraborty, C. AU - Lala, P. K. PY - 2001 DA - 2001// TI - Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis JO - Int J Cancer VL - 93 UR - https://doi.org/10.1002/ijc.1376 DO - 10.1002/ijc.1376 ID - Rozic2001 ER - TY - JOUR AU - Timoshenko, A. V. AU - Xu, G. AU - Chakrabarti, S. AU - Lala, P. K. AU - Chakraborty, C. PY - 2003 DA - 2003// TI - Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells JO - Exp Cell Res VL - 289 UR - https://doi.org/10.1016/S0014-4827(03)00269-6 DO - 10.1016/S0014-4827(03)00269-6 ID - Timoshenko2003 ER - TY - JOUR AU - Timoshenko, A. V. AU - Lala, P. K. AU - Chakraborty, C. PY - 2004 DA - 2004// TI - PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors JO - Int J Cancer VL - 108 UR - https://doi.org/10.1002/ijc.11575 DO - 10.1002/ijc.11575 ID - Timoshenko2004 ER - TY - JOUR AU - Timoshenko, A. V. AU - Chakraborty, C. AU - Wagner, G. F. AU - Lala, P. K. PY - 2006 DA - 2006// TI - COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6603067 DO - 10.1038/sj.bjc.6603067 ID - Timoshenko2006 ER - TY - JOUR AU - Bhattacharjee, R. N. AU - Timoshenko, A. V. AU - Cai, J. AU - Lala, P. K. PY - 2010 DA - 2010// TI - Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2010.01647.x DO - 10.1111/j.1349-7006.2010.01647.x ID - Bhattacharjee2010 ER - TY - JOUR AU - Xin, X. AU - Majumder, M. AU - Girish, G. V. AU - Mohindra, V. AU - Maruyama, T. AU - Lala, P. K. PY - 2012 DA - 2012// TI - Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model JO - Lab Invest VL - 92 UR - https://doi.org/10.1038/labinvest.2012.90 DO - 10.1038/labinvest.2012.90 ID - Xin2012 ER - TY - JOUR AU - Lyons, T. R. AU - Borges, V. F. AU - Betts, C. B. AU - Guo, Q. AU - Kapoor, P. AU - Martinson, H. A. PY - 2014 DA - 2014// TI - Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI73777 DO - 10.1172/JCI73777 ID - Lyons2014 ER - TY - JOUR AU - Chuang, C. W. AU - Pan, M. R. AU - Hou, M. F. AU - Hung, W. C. PY - 2013 DA - 2013// TI - Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells JO - J Cell Physiol VL - 228 UR - https://doi.org/10.1002/jcp.24136 DO - 10.1002/jcp.24136 ID - Chuang2013 ER - TY - JOUR AU - Wang, J. AU - Zhang, X. AU - Thomas, S. M. AU - Grandis, J. R. AU - Wells, A. AU - Chen, Z. G. PY - 2005 DA - 2005// TI - Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208740 DO - 10.1038/sj.onc.1208740 ID - Wang2005 ER - TY - JOUR AU - Liu, F. Y. AU - Zhao, Z. J. AU - Li, P. AU - Ding, X. AU - Zong, Z. H. AU - Sun, C. F. PY - 2010 DA - 2010// TI - Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck JO - Br J Oral Maxillofac Surg VL - 48 UR - https://doi.org/10.1016/j.bjoms.2009.06.007 DO - 10.1016/j.bjoms.2009.06.007 ID - Liu2010 ER - TY - JOUR AU - Xu, Y. AU - Liu, L. AU - Qiu, X. AU - Jiang, L. AU - Huang, B. AU - Li, H. PY - 2011 DA - 2011// TI - CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0021119 DO - 10.1371/journal.pone.0021119 ID - Xu2011 ER - TY - JOUR AU - Xu, Y. AU - Liu, L. AU - Qiu, X. AU - Liu, Z. AU - Li, H. AU - Li, Z. PY - 2012 DA - 2012// TI - CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0033262 DO - 10.1371/journal.pone.0033262 ID - Xu2012 ER - TY - JOUR AU - Bruyere, F. AU - Noel, A. PY - 2010 DA - 2010// TI - Lymphangiogenesis: in vitro and in vivo models JO - FASEB J VL - 24 UR - https://doi.org/10.1096/fj.09-132852 DO - 10.1096/fj.09-132852 ID - Bruyere2010 ER - TY - JOUR AU - Patel, S. AU - Iozzo, R. V. PY - 2001 DA - 2001// TI - Measuring single-cell cytosolic Ca2+ concentration in response to proteoglycans JO - Methods Mol Biol VL - 171 ID - Patel2001 ER - TY - JOUR AU - Majumder, M. AU - Xin, X. AU - Lala, P. K. PY - 2013 DA - 2013// TI - A practical and sensitive method of quantitating lymphangiogenesis in vivo JO - Lab Invest VL - 93 UR - https://doi.org/10.1038/labinvest.2013.72 DO - 10.1038/labinvest.2013.72 ID - Majumder2013 ER - TY - JOUR AU - Nakamura, Y. AU - Yasuoka, H. AU - Tsujimoto, M. AU - Imabun, S. AU - Nakahara, M. AU - Nakao, K. PY - 2005 DA - 2005// TI - Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer JO - Breast Cancer Res Treat VL - 91 UR - https://doi.org/10.1007/s10549-004-5783-x DO - 10.1007/s10549-004-5783-x ID - Nakamura2005 ER - TY - JOUR AU - Christiansen, A. AU - Detmar, M. PY - 2011 DA - 2011// TI - Lymphangiogenesis and cancer JO - Genes Cancer VL - 2 UR - https://doi.org/10.1177/1947601911423028 DO - 10.1177/1947601911423028 ID - Christiansen2011 ER - TY - JOUR AU - Lund, A. W. AU - Swartz, M. A. PY - 2010 DA - 2010// TI - Role of lymphatic vessels in tumor immunity: passive conduits or active participants? JO - J Mammary Gland Biol Neoplasia VL - 15 UR - https://doi.org/10.1007/s10911-010-9193-x DO - 10.1007/s10911-010-9193-x ID - Lund2010 ER - TY - JOUR AU - Lund, A. W. AU - Duraes, F. V. AU - Hirosue, S. AU - Raghavan, V. R. AU - Nembrini, C. AU - Thomas, S. N. PY - 2012 DA - 2012// TI - VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics JO - Cell Rep VL - 1 UR - https://doi.org/10.1016/j.celrep.2012.01.005 DO - 10.1016/j.celrep.2012.01.005 ID - Lund2012 ER - TY - JOUR AU - Swartz, M. A. PY - 2014 DA - 2014// TI - Immunomodulatory roles of lymphatic vessels in cancer progression JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-14-0115 DO - 10.1158/2326-6066.CIR-14-0115 ID - Swartz2014 ER - TY - JOUR AU - Worbs, T. AU - Forster, R. PY - 2007 DA - 2007// TI - A key role for CCR7 in establishing central and peripheral tolerance JO - Trends Immunol VL - 28 UR - https://doi.org/10.1016/j.it.2007.04.002 DO - 10.1016/j.it.2007.04.002 ID - Worbs2007 ER - TY - CHAP AU - Fang, L. AU - Hwang, S. T. PY - 2009 DA - 2009// TI - Roles for CCR7 in Cancer Biology BT - Chemokine Receptors in Cancer UR - https://doi.org/10.1007/978-1-60327-267-4_6 DO - 10.1007/978-1-60327-267-4_6 ID - Fang2009 ER - TY - JOUR AU - Karpanen, T. AU - Egeblad, M. AU - Karkkainen, M. J. AU - Kubo, H. AU - Yla-Herttuala, S. AU - Jaattela, M. PY - 2001 DA - 2001// TI - Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth JO - Cancer Res VL - 61 ID - Karpanen2001 ER - TY - JOUR AU - Norrmen, C. AU - Tammela, T. AU - Petrova, T. V. AU - Alitalo, K. PY - 2011 DA - 2011// TI - Biological basis of therapeutic lymphangiogenesis JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.704098 DO - 10.1161/CIRCULATIONAHA.107.704098 ID - Norrmen2011 ER - TY - JOUR AU - Deguchi, K. AU - Ichikawa, D. AU - Soga, K. AU - Watanabe, K. AU - Kosuga, T. AU - Takeshita, H. PY - 2010 DA - 2010// TI - Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer JO - Anticancer Res VL - 30 ID - Deguchi2010 ER - TY - JOUR AU - Stacker, S. A. AU - Williams, S. P. AU - Karnezis, T. AU - Shayan, R. AU - Fox, S. B. AU - Achen, M. G. PY - 2014 DA - 2014// TI - Lymphangiogenesis and lymphatic vessel remodelling in cancer JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3677 DO - 10.1038/nrc3677 ID - Stacker2014 ER - TY - JOUR AU - Tang, Y. AU - Zhang, D. AU - Fallavollita, L. AU - Brodt, P. PY - 2003 DA - 2003// TI - Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor JO - Cancer Res VL - 63 ID - Tang2003 ER - TY - JOUR AU - Zimmermann, N. AU - Conkright, J. J. AU - Rothenberg, M. E. PY - 1999 DA - 1999// TI - CC chemokine receptor-3 undergoes prolonged ligand-induced internalization JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.18.12611 DO - 10.1074/jbc.274.18.12611 ID - Zimmermann1999 ER - TY - JOUR AU - Nagira, M. AU - Imai, T. AU - Hieshima, K. AU - Kusuda, J. AU - Ridanpaa, M. AU - Takagi, S. PY - 1997 DA - 1997// TI - Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13 JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.31.19518 DO - 10.1074/jbc.272.31.19518 ID - Nagira1997 ER - TY - JOUR AU - Hedrick, J. A. AU - Zlotnik, A. PY - 1997 DA - 1997// TI - Identification and characterization of a novel beta chemokine containing six conserved cysteines JO - J Immunol VL - 159 ID - Hedrick1997 ER - TY - JOUR AU - Sironi, M. AU - Conti, A. AU - Bernasconi, S. AU - Fra, A. M. AU - Pasqualini, F. AU - Nebuloni, M. PY - 2006 DA - 2006// TI - Generation and characterization of a mouse lymphatic endothelial cell line JO - Cell Tissue Res VL - 325 UR - https://doi.org/10.1007/s00441-006-0171-y DO - 10.1007/s00441-006-0171-y ID - Sironi2006 ER - TY - JOUR AU - Oliveira-Neto, H. H. AU - Souza, P. P. AU - Silva, M. R. AU - Mendonca, E. F. AU - Silva, T. A. AU - Batista, A. C. PY - 2013 DA - 2013// TI - The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis JO - Tumour Biol VL - 34 UR - https://doi.org/10.1007/s13277-012-0511-3 DO - 10.1007/s13277-012-0511-3 ID - Oliveira-Neto2013 ER - TY - JOUR AU - Lanati, S. AU - Dunn, D. B. AU - Roussigné, M. AU - Emmett, M. S. AU - Carriere, V. AU - Jullien, D. PY - 2010 DA - 2010// TI - Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-0175 DO - 10.1158/0008-5472.CAN-10-0175 ID - Lanati2010 ER - TY - JOUR AU - Lin, Y. AU - Sharma, S. AU - John, M. S. PY - 2014 DA - 2014// TI - CCL21 cancer immunotherapy JO - Cancers VL - 6 UR - https://doi.org/10.3390/cancers6021098 DO - 10.3390/cancers6021098 ID - Lin2014 ER - TY - JOUR AU - Baratelli, F. AU - Takedatsu, H. AU - Hazra, S. AU - Peebles, K. AU - Luo, J. AU - Kurimoto, P. S. PY - 2008 DA - 2008// TI - Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer JO - J Transl Med VL - 6 UR - https://doi.org/10.1186/1479-5876-6-38 DO - 10.1186/1479-5876-6-38 ID - Baratelli2008 ER -